Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Invesco Biotechnology & Genome ETF (NY:PBE)

72.80 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1
Open 72.80
Bid (Size) 71.71 (35)
Ask (Size) 73.83 (34)
Prev. Close 72.80
Today's Range 72.80 - 72.80
52wk Range 54.52 - 73.88
Shares Outstanding 34,500
Dividend Yield 0.64%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Akebia Therapeutics Stock Slumps After FDA Meeting Ends Without Path Forward for Vafseo Label Expansion
Via Stocktwits
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk
The U.S. pharmaceutical industry is at the center of a policy maelstrom. 
Via Benzinga
Topics ETFs

Performance

YTD
+8.5%
+8.5%
1 Month
+5.3%
+5.3%
3 Month
+10.6%
+10.6%
6 Month
+16.9%
+16.9%
1 Year
+5.8%
+5.8%

More News

Read More
Ionis Pharma Stock Rises After Multiple Price Target Hikes On Heels Of Positive Study Results In Alexander Disease
Via Stocktwits
3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential
Via InvestorPlace
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
Via Benzinga
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
Via Benzinga
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
Via Benzinga
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
Via Benzinga
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
Via Benzinga
US Judge Weighs Nationwide Ban On Abortion Pills
Via Benzinga
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
Via Benzinga
7 Best Biotech Stocks to Buy in July 2022
Via InvestorPlace
Biotech ETFs That Outperformed Last Week
Via Talk Markets
A Comprehensive Guide To Genomic ETFs
Via Talk Markets
5 Top ETFs With Exposure To Biogen
Via Talk Markets
5 Top ETFs With Exposure To Biogen
Via Benzinga
3 Biotech Stocks Wall Street Predicts Will Rally By 45% Or More
Via Talk Markets

Frequently Asked Questions

Is Invesco Biotechnology & Genome ETF publicly traded?
Yes, Invesco Biotechnology & Genome ETF is publicly traded.
What exchange does Invesco Biotechnology & Genome ETF trade on?
Invesco Biotechnology & Genome ETF trades on the New York Stock Exchange
What is the ticker symbol for Invesco Biotechnology & Genome ETF?
The ticker symbol for Invesco Biotechnology & Genome ETF is PBE on the New York Stock Exchange
What is the current price of Invesco Biotechnology & Genome ETF?
The current price of Invesco Biotechnology & Genome ETF is 72.80
When was Invesco Biotechnology & Genome ETF last traded?
The last trade of Invesco Biotechnology & Genome ETF was at 10/29/25 08:00 PM ET
What is the market capitalization of Invesco Biotechnology & Genome ETF?
The market capitalization of Invesco Biotechnology & Genome ETF is 2.51M
How many shares of Invesco Biotechnology & Genome ETF are outstanding?
Invesco Biotechnology & Genome ETF has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.